Back
NeoGenomics Vs. Ensysce Biosciences Industry Stock Comparison
Sell
46
NEO
NeoGenomics
Last Price:
$7.99
Seasonality Move:
11.27%
Sell
38
ENSC
Ensysce Biosciences
Last Price:
$2.40
Seasonality Move:
-24.76%
Sell
46
NeoGenomics (NEO)
is a Sell
Is NeoGenomics a Buy, Sell or Hold?
-
The current NeoGenomics [NEO] share price is $7.99. The Score for NEO is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
-
NEO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
38
Ensysce Biosciences (ENSC)
is a Sell
Is Ensysce Biosciences a Buy, Sell or Hold?
-
The current Ensysce Biosciences [ENSC] share price is $2.42. The Score for ENSC is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
-
ENSC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NEO Stock Price Chart
What is NeoGenomics's stock price today?
-
The NeoGenomics share price today is $7.99Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NEO is experiencing slight selling pressure.
ENSC Stock Price Chart
What is Ensysce Biosciences's stock price today?
-
The Ensysce Biosciences share price today is $2.42Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ENSC is experiencing slight selling pressure.
NEO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.34 | Sell |
Relative Strength Index (14 RSI): | 44.1 | Sell |
Chaikin Money Flow: | -430910 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.42 - 9.58) | Sell |
Bollinger Bands (100): | (8.41 - 14.59) | Sell |
ENSC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.14 | Sell |
Relative Strength Index (14 RSI): | 48.07 | Sell |
Chaikin Money Flow: | -28925 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.93 - 2.97) | Sell |
Bollinger Bands (100): | (2.47 - 7.03) | Sell |
NEO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 8.11 | Sell |
20-day SMA: | 8.23 | Sell |
50-day SMA: | 9.02 | Sell |
200-day SMA: | 13.62 | Sell |
8-day EMA: | 8.05 | Sell |
20-day EMA: | 8.28 | Sell |
50-day EMA: | 9.25 | Sell |
200-day EMA: | 12.45 | Sell |
ENSC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.27 | Buy |
20-day SMA: | 2.59 | Sell |
50-day SMA: | 2.74 | Sell |
200-day SMA: | 5.52 | Sell |
8-day EMA: | 2.35 | Buy |
20-day EMA: | 2.42 | Buy |
50-day EMA: | 3.03 | Sell |
200-day EMA: | 14.1 | Sell |
NeoGenomics Earnings Growth & NEO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.04 per share, an increase next quarter of $0.03 per share, an increase this year of $0.06 per share, and an increase next year of $0.16 per share.
Ensysce Biosciences Earnings Growth & ENSC Earnings Dates
-
Analysts estimate an earnings increase this quarter of $4.32 per share, an increase next quarter of $0.47 per share, an increase this year of $8.13 per share, and an increase next year of $2.09 per share.
NeoGenomics Technical Analysis
May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | May 16 | May 19 | May 20 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
07 | 08 | 09 | 12 | 13 | 14 | 15 | 16 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Ensysce Biosciences Technical Analysis
May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | May 16 | May 19 | May 20 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
07 | 08 | 09 | 12 | 13 | 14 | 15 | 16 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |